bpc 157 and semaglutide Semaglutide/BPC – Peptide Research Blog Australia —

Standard human dosing protocols based on animal studies suggest 0.25-0.5 mg daily via subcutaneous injection for 4-8 weeks

Diarrhea has resulted from oral dosages of more than 1 gram daily

The study has been performed in accordance with the Declaration of Helsinki

The Z-track method is preferable to other methods for IM injections as it prevents leakage

However, annual review with your GP is advisable to: Ensure adherence to the injection schedule Monitor for any new or worsening symptoms Consider testing for other autoimmune conditions if symptoms develop (particularly thyroid function, as thyroid disease is commonly associated with pernicious anaemia) [2] Gastric cancer risk: Pernicious anaemia is associated with a slightly increased risk of gastric cancer

Email Us!